Eortc MoBilE Device (EMBED)

This study is a longitudinal observational study that will investigate the feasibility of using mobile devices for the assessment of HRQoL and physical activity in adult cancer patients undergoing treatment. Patients will complete a set of patient reported outcome measures (PROMs), and wear a smartwatch (min. 10 hours per day for one week), at baseline, and at weeks 4, 8 and 12 after treatment start.

NCT Number	NCT07711080
Lead Sponsor	European Organisation for Research and Treatment of Cancer - EORTC
Conditions	Diagnosis of Cancer
Enrollment	137 participants
Start Date	2026-09-01
Primary Completion	2028-09-01 (estimated)
Study Completion	2028-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-17